About Curis
|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
128 Spring St, Building C - Suite 500, Lexington, Massachusetts 02421, US
|
|
Curis | 3,820 followers on LinkedIn. Working relentlessly to develop innovative and differentiated therapeutics that improve the lives of cancer patients. | Curis is a publicly-traded biotechnology company (NASDAQ: CRIS) focused on the development of first-in-class and innovative therapeutics or the treatment of cancer. The Company currently has three drug candidates in development:
CA-4948, an orally-available, small molecule inhibitor of the IRAK4 kinase being investigated in a Phase 1 clinical trial in patients with non-Hodgkin's lymphoma and in a separate Phase 1 trial for acute myeloid leukemia and myelodysplastic syndromes.
|
Curis Email Format
The widely used Curis email format is {f}{last}@curis.com (e.g. [email protected]), which is used 100% of the time.
| Curis Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {f}{last} | [email protected] |
100%
|
Curis Alternatives
Frequently Asked Questions about Curis
What is Curis email format?
The widely used Curis email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
What is Curis customer service number?
To contact Curis customer service number in your country click here to find.
Curis Staff Directory
Search Curis Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
